Ecopia BioSciences' Merger

Ecopia BioSciences raised a round of funding on March 14, 2007. Investors include Thallion Pharmaceuticals.

Ecopia is finding anticancer therapies from microorganisms, one of the most prolific sources of drugs. The company's focus is to move lead compound, ECO-4601, through the different stages of its Phase…

Articles about Ecopia BioSciences' Merger: